22/09/2024

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

22/09/2024

Sep 22, 2024, 12:16 | Blog
UICC Report on Integrated approaches for women’s cancers - IARC
Partha Basu Head of Early Detection, Prevention and Infections Branch at International Agency for Research…
Sep 22, 2024, 12:09 | Blog
Louise Abbott: Top 3 takeaways from women's cancer sessions at WCC2024
Louise Abbott, Head of International Practice at Evoke Incisive Health, shared a post on LinkedIn:…
Sep 22, 2024, 11:55 | Blog
American Cancer Society and WIN Consortium join forces to advance innovative Cancer research - WIN Consortium
WIN Consortium shared a post on X: "American Cancer Society and WIN Consortium join forces to…
Sep 22, 2024, 10:49 | Insight
15 Posts Not To Miss From COSMO24
The Collaboration for Outcomes Using Social Media in Oncology (COSMO) Conference took place from September…
Sep 22, 2024, 10:09 | Blog
Jozef Suvada: Mapping Cancer Care Priorities at the UN
Jozef Suvada shared a post on LinkedIn: ''Mapping Cancer Care Priorities at the UN, Reflecting…
Sep 22, 2024, 09:44 | Insight
Myeloma Paper of the Day, September 22nd, suggested by Robert Orlowski
Robert Orlowski shared on X: “Myeloma Paper of the Day: Optical genome mapping in conjunction with…
Sep 22, 2024, 09:31 | Blog
Isabel Mestres: When a global community listens to local voices, real change happens!
Isabel Mestres posted on LinkedIn: "'Proud moment! The City Cancer Challenge team took the global…
Sep 22, 2024, 09:21 | Blog
Sergio Cifuentes Canaval about his experience oncology rotation abroad in Spain
Sergio Cifuentes Canaval, Cancer Research Project Manager at CENEIT Mexico, shared on LinkedIn: "Hello everyone!…
Sep 22, 2024, 09:05 | Societies
Breaking Science in Gastrointestinal Cancers with Kohei Shitara - ESMO
ESMO shared on LinkedIn: “For ESMO members: Breaking Science in Gastrointestinal Cancers. Kohei Shitara talks…
Sep 22, 2024, 09:05 | Blog
Amol Akhade: Oncologists' preferences following the approval of adjuvant ribociclib
Amol Akhade shared a post on LinkedIn: ''We recently conducted an online poll to gauge…
All: 84 Posts: 51 - 60
Special Coverage